Literature DB >> 21178276

Rac GTPases in human diseases.

Sung-Yun Pai1, Chaekyun Kim, David A Williams.   

Abstract

Rho GTPases are members of the Ras superfamily of GTPases that regulate a wide variety of cellular functions. While Rho GTPase pathways have been implicated in various pathological conditions in humans, to date coding mutations in only the hematopoietic specific GTPase, RAC2, have been found to cause a human disease, a severe phagocytic immunodeficiency characterized by life-threatening infections in infancy. Interestingly, the phenotype was predicted by a mouse knock-out of Rac2 and resembles leukocyte adhesion deficiency (LAD). Here we review Rho GTPases with a specific focus on Rac GTPases. In particular, we discuss a new understanding of the unique and overlapping roles of Rac2 in blood cells that has developed since the generation of mice deficient in Rac1, Rac2 and Rac3 proteins. We propose that Rac2 mutations leading to disease be termed LAD type IV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178276      PMCID: PMC3835286          DOI: 10.3233/DMA-2010-0738

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  27 in total

1.  Activation of PAK by a bacterial type III effector EspG reveals alternative mechanisms of GTPase pathway regulation.

Authors:  Andrey S Selyunin; Neal M Alto
Journal:  Small GTPases       Date:  2011-07-01

2.  ArhGAP15, a Rac-specific GTPase-activating protein, plays a dual role in inhibiting small GTPase signaling.

Authors:  Maria Radu; Sonali J Rawat; Alexander Beeser; Anton Iliuk; Weiguo Andy Tao; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

3.  Dual roles for Rac2 in neutrophil motility and active retention in zebrafish hematopoietic tissue.

Authors:  Qing Deng; Sa Kan Yoo; Peter J Cavnar; Julie M Green; Anna Huttenlocher
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

4.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 5.  Neutrophil migration: moving from zebrafish models to human autoimmunity.

Authors:  Miriam A Shelef; Sebastien Tauzin; Anna Huttenlocher
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

6.  Neutrophil beta2 integrin inhibition by enhanced interactions of vasodilator-stimulated phosphoprotein with S-nitrosylated actin.

Authors:  Stephen R Thom; Veena M Bhopale; Ming Yang; Marina Bogush; Shaohui Huang; Tatyana N Milovanova
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

7.  Optical Tools To Study the Isoform-Specific Roles of Small GTPases in Immune Cells.

Authors:  Veronika Miskolci; Bin Wu; Yasmin Moshfegh; Dianne Cox; Louis Hodgson
Journal:  J Immunol       Date:  2016-03-07       Impact factor: 5.422

8.  A GEF-to-phospholipase molecular switch caused by phosphatidic acid, Rac and JAK tyrosine kinase that explains leukocyte cell migration.

Authors:  Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

Review 9.  Immune and regulatory functions of neutrophils in inflammatory bone loss.

Authors:  George Hajishengallis; Niki M Moutsopoulos; Evlambia Hajishengallis; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2016-02-28       Impact factor: 11.130

10.  Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injury.

Authors:  Swasti Chaturvedi; Darren A Yuen; Amandeep Bajwa; Yi-Wei Huang; Christiane Sokollik; Liping Huang; Grace Y Lam; Soumitra Tole; Guang-Ying Liu; Jerry Pan; Lauren Chan; Yaro Sokolskyy; Manoj Puthia; Gabriela Godaly; Rohan John; Changsen Wang; Warren L Lee; John H Brumell; Mark D Okusa; Lisa A Robinson
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.